Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Walzer

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Market Access Pathway for Medical Nutrition in Europe and The UsSéverac H Chevrou, D Droeschel, S Walzer
Annual Review of Medicine|January 1, 1978
The XYY genotypeS Walzer, P S Gerald, S A Shah
Birth Defects Original Article Series|January 1, 1990
Cognitive and behavioral factors in the learning disabilities of 47,XXY and 47,XYY boysS Walzer, A S Bashir, A R Silbert
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Is it Possible to Predict The Market Access of a New Pharmaceutical in Germany? A Systematic Evaluation of Federal Joint Committee Decisions on Early Benefit Assessments According to The German Law For Reforming The Market of PharmaceuticalsB Schwander, K Banz, K Kaier, et al.
Community Mental Health Journal|November 2, 2013
The mental health rehabilitation worker: A new member of the psychiatric teamI F Davidoff, A C Lauga, R S Walzer
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
A Comparison of Market Access Evaluations for new Oncology Therapies in France, Germany and the UK: An Analysis Using the Prismaccess DatabaseD Droeschel, B de Paz, D Houzelot, et al.
Der Orthopade|October 8, 2017
[Therapeutic utilization of stem cells in orthopedics]C Chiari, S Walzer, D Stelzeneder, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 11, 2008
Insulin glargine added to therapy with oral antidiabetic agents improves glycemic control and reduces long-term complications in patients with type 2 diabetes - a simulation with the Diabetes Mellitus Model (DMM)H U Janka, F Hessel, S Walzer, et al.
Psychology, Health & Medicine|January 21, 2016
Other- versus self-focus and risky health behavior: the case of HIV/AIDSAmy S Walzer, Kelvin L Van Manen, Carey S Ryan
Der Orthopade|January 7, 2018
[Correction to: Therapeutic use of stem cells in orthopedics]C Chiari, S Walzer, D Stelzeneder, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Market Access Pathway for Medical Nutrition in Europe and The UsSéverac H Chevrou, D Droeschel, S Walzer
Annual Review of Medicine|January 1, 1978
The XYY genotypeS Walzer, P S Gerald, S A Shah
Birth Defects Original Article Series|January 1, 1990
Cognitive and behavioral factors in the learning disabilities of 47,XXY and 47,XYY boysS Walzer, A S Bashir, A R Silbert
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Is it Possible to Predict The Market Access of a New Pharmaceutical in Germany? A Systematic Evaluation of Federal Joint Committee Decisions on Early Benefit Assessments According to The German Law For Reforming The Market of PharmaceuticalsB Schwander, K Banz, K Kaier, et al.
Community Mental Health Journal|November 2, 2013
The mental health rehabilitation worker: A new member of the psychiatric teamI F Davidoff, A C Lauga, R S Walzer
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
A Comparison of Market Access Evaluations for new Oncology Therapies in France, Germany and the UK: An Analysis Using the Prismaccess DatabaseD Droeschel, B de Paz, D Houzelot, et al.
Der Orthopade|October 8, 2017
[Therapeutic utilization of stem cells in orthopedics]C Chiari, S Walzer, D Stelzeneder, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 11, 2008
Insulin glargine added to therapy with oral antidiabetic agents improves glycemic control and reduces long-term complications in patients with type 2 diabetes - a simulation with the Diabetes Mellitus Model (DMM)H U Janka, F Hessel, S Walzer, et al.
Psychology, Health & Medicine|January 21, 2016
Other- versus self-focus and risky health behavior: the case of HIV/AIDSAmy S Walzer, Kelvin L Van Manen, Carey S Ryan
Der Orthopade|January 7, 2018
[Correction to: Therapeutic use of stem cells in orthopedics]C Chiari, S Walzer, D Stelzeneder, et al.
Pageof 4